RxDoctor Payments Data

Stephen Adams, MD

Family Medicine · Montrose, CONPI 1740486646

Payments from drug & device makers

$1,558in general payments, 2019–2025

Across 89 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$409
  • Astellas Pharma US Inc$239
  • Pfizer$124
  • Johnson & Johnson$110
  • Lilly USA, LLC$97
  • AstraZeneca$89
  • plus $490 from 15 others

What the payments were for

  • Food & beverage$1,558100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,558 in reported general payments places this provider in the 85th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$90,434
Medicare patients
256
Services billed
1,663

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban81$56,088
TrulicityDulaglutide13$29,080
MyrbetriqMirabegron47$27,359
JardianceEmpagliflozin21$26,923
MounjaroTirzepatide32$24,869
XareltoRivaroxaban41$22,590
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$19,806
OzempicSemaglutide19$19,612
Repatha SureclickEvolocumab11$6,074
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$5,620
Atorvastatin Calcium350$2,846
Gabapentin90$2,282
Levothyroxine Sodium147$1,530
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,304
Lisinopril195$1,259

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$124$56,08881 claims
Lilly USA, LLCTrulicity, Mounjaro$97$53,94945 claims
Astellas Pharma US IncMyrbetriq$239$27,35947 claims
Johnson & JohnsonXarelto$110$22,59041 claims
GSKTrelegy Ellipta$44$19,80623 claims
Novo NordiskOzempic$16$19,61219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Montrose

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →